Fate Therapeutics Reports First Quarter 2020 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports First Quarter 2020 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.35 -0.08 (3.29%)
Previous Close $2.43    52 Week High $4.76 
Open $2.42    52 Week Low $1.46 
Day High $2.42    P/E N/A 
Day Low $2.25    EPS $-1.91 
Volume 1,310,224